Article Details
Retrieved on: 2025-08-07 17:27:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche, following its acquisition of Carmot Therapeutics, is working on CT-966, an oral GLP-1 agonist. CT-966 resulted in a placebo-adjusted average ...
Article found on: kfgo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here